US$ 29.67
patent for semaglutide Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants, Semaglutide generics flood Indian market
Description
OpenAI CEO Sam Altman confirmed in a blog post Wednesday that he was returning to the helm of the company he cofounded, nearly two weeks after being ousted.
Complete guide with dosage charts.

No clinical evidence demonstrates that GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, or tirzepatide) improve symptoms of postural orthostat...

Ageing and fertility are intertwined

PlexusDx helps you understand your treatment timeline and long-term maintenance options

Please consult a healthcare professional before using any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition